CA
NZ
UK
AU
IND
US
Myriad Genetics (NASDAQ:MYGN) shares traded up 37.09% to $5.77 after a definitive agreement for Labcorp (NYSE:LH) to buy its Prenatal Health testing business for $210 million in cash plus the value of inventory at closing. Volume reached about 20.24 million shares.
ORIC Pharmaceuticals (NASDAQ:ORIC) shares traded up 9.20% to $13.89 as investors positioned for enozertinib data at the ESMO Congress in Madrid from Oct. 23 to 27. Abstracts were published this week, and the company will host a call and webcast on Oct. 23 to …
QuidelOrtho (NASDAQ:QDEL) shares traded up 12.18% to $14.31 after the company said it will report Q3 results shortly after the market closes on Nov. 3, followed by a conference call and webcast. The date is earlier than the roughly Nov. 5 that data providers …
Rapport Therapeutics (NASDAQ:RAPP) shares traded up 2.55% to $29.33 after the company reported positive topline Phase 2 results for RAP-219 in acute bipolar mania. The trial enrolled 253 adults and met its primary endpoint, a 3.1-point placebo-adjusted improvement in the Young Mania Rating Scale …
Revolution Medicines (NASDAQ:RVMD) shares traded up 6.66% to $194.28 after the company said it had begun treating patients in RASolve 308. The global Phase 3 trial tests zoldonrasib with pembrolizumab and platinum chemotherapy against placebo plus the same regimen in previously untreated metastatic RAS …
Sanofi (NASDAQ:SNY) shares traded up 4.27% to $41.26 after it and Teva (NYSE:TEVA) shared new Phase 2b long-term extension data for duvakitug, a TL1A antibody. In ulcerative colitis, the 900 mg dose delivered 58% clinical remission and 87% clinical response at Week 44, against …
Zenas BioPharma (NASDAQ:ZBIO) shares traded up 10.97% to $29.64 after Morgan Stanley started coverage at Equalweight with a $32 target, saying obexelimab looks approvable in IgG4-related disease. The initiation joined upbeat Phase 3 INDIGO extension data and a PDUFA date of May 27, 2027.
Doximity (NYSE:DOCS) shares traded up 7.49% to $33.81 after the company and Wolters Kluwer Health announced that UpToDate's evidence-based clinical content will be accessible within Doximity Ask. In the coming weeks, clinicians at health systems using both products will see answers based on UpToDate's …
Heartflow (NASDAQ:HTFL) shares traded up 8.27% to $55.24, near a 52-week high of $55.46, as investors responded to Piper Sandler raising its price target to $64 from $45 while keeping an Overweight rating. The firm cited the company's competitive moat.
Omada Health (NASDAQ:OMDA) shares traded up 6.36% to $19.21 after the company announced it will present peer-reviewed research at the World Obesity and Weight Management Congress in Boston. The findings were published in the journal Diabetes, Obesity and Metabolism.
Please wait processing your request...